Primovist enhanced liver MRI – Benefits in HCC liver disease management and patient outcome - ESR Connect

Industry Symposium by Bayer

SY 02 - Primovist enhanced liver MRI – Benefits in HCC liver disease management and patient outcome

March 3, 09:15 - 10:15 CET

  • 2 Lectures
  • 60 Minutes
  • 2 Speakers
MyScheduleUn-Schedule

Description

SY 02-1
30 min
Liver Disease Management & Q/A
Max Seidensticker, Munich / Germany
Present diagnostic results of the SORAMIC trial
Put results into broader context of HCC liver disease management
Significance of results for HCC management in Europe
Trends and data APAC vs. Europe /US
Management of non-enhancing hypointense nodules
Future outlook HCC liver disease management
What would be needed in Europe?
SY 02-2
30 min
Patient Outcomes & Q/A
Tae Wook Kang, Seoul / KOR
Present results from nation-wide analysis Korea
Put results into broader context of other HCC outcome studies involving Primovist (+ combination with CT)
Significance of results in APAC
How could learnings from Korea results be transferred to Europe/US?
Future outlook for best practice in HCC management to further lower HCC mortality (in Eastern & Western Countries)
What could Europe/US learn from Korea?

Moderators

Presenter

Max Seidensticker

Gräfelfing, Germany

Presenter

Tae Wook Kang

Seoul, Korea, Republic of

Speakers

Presenter

Max Seidensticker

Gräfelfing, Germany

Presenter

Tae Wook Kang

Seoul, Korea, Republic of